Pancreas Artificial
Mostrando 1-12 de 15 artigos, teses e dissertações.
-
1. Experiência clínica com um sistema de infusão de insulina de alça fechada implantável
OBJETIVO: Relatar a primeira experiência clínica com um protótipo de célulabeta artificial implantável. MÉTODOS: O Projeto de Um Sistema Sensor de Longo Prazo avaliou a possibilidade do controle glicêmico através do implante combinado de uma bomba de infusão de insulina peritoneal e um gluco - sensor endovenoso central - conectados fisicamente por u
Arquivos Brasileiros de Endocrinologia & Metabologia. Publicado em: 2008-03
-
2. Bomba de infusão de insulina em diabetes melito tipo 1
OBJETIVO: Rever a experiência com a utilização da bomba de infusão de insulina em crianças e adolescentes, a fim de orientar o pediatra quanto às suas indicações e complicações. FONTE DOS DADOS : Foi realizada revisão sistemática de artigos publicados em literatura que abordassem a utilização da bomba de infusão de insulina, suas indicações,
Jornal de Pediatria. Publicado em: 2006-08
-
3. Efeito do ciclamato de sódio sobre o pâncreas exócrino fetal de ratos: estudo cariométrico e esterelógico.
Cyclamate, a sweetening substance derived from N-cyclo-hexyl-sulfamic acid, is largely used as a non-caloric artificial edulcorant in foods and beverages as well as in the pharmaceutical industry. This study aims at evaluating different karyometric and stereological quantitative parameters in the exocrine pancreas of rat fetuses . In five pregnant rats, a do
Publicado em: 2006
-
4. Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients.
Ten insulin dependent diabetic patients were maintained in normoglycaemia for 36 h with an artificial pancreas. Circulating polymorphonuclear leucocytes were extracted and incubated with staphylococcus before and after treatment; phagocytic and bactericidal activities were studied. Granulocytes from diabetic patients showed a decreased ability to absorb stap
-
5. Juvenile Diabetes Research Foundation Artificial Pancreas Consortium Update
Diabetes Technology Society.
-
6. Automatic Data Processing to Achieve a Safe Telemedical Artificial Pancreas
Diabetes Technology Society.
-
7. A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator
The objective of this article is to present a comprehensive strategy for a closed-loop artificial pancreas. A meal detection and meal size estimation algorithm is developed for situations in which the subject forgets to provide a meal insulin bolus. A pharmacodynamic model of insulin action is used to provide insulin-on-board constraints to explicitly includ
Diabetes Technology Society.
-
8. Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience
Diabetes Technology Society.
-
9. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
BioMed Central.
-
10. Progress in Development of an Artificial Pancreas
This issue of Journal of Diabetes Science and Technology contains a collection of 12 original articles describing the latest advances in the development of algorithms for controlling insulin delivery in an artificial pancreas. Algorithms presented in this issue are affected by numerous quantifiable factors, including insulin pharmaco-kinetics, timing of meal
Diabetes Technology Society.
-
11. Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier
New effort has been made to develop closed-loop glucose control, using subcutaneous (SC) glucose sensing and continuous subcutaneous insulin infusion (CSII) from a pump, and a control algorithm. An approach based on a model predictive control (MPC) algorithm has been utilized during closed-loop control in type 1 diabetes patients. Here we describe the prelim
Diabetes Technology Society.
-
12. Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis
Clinical and laboratory investigations have demonstrated the involvement of viruses and bacteria as potential causative agents in cardiovascular disease and have specifically found coxsackievirus B3 (CVB3) to be a leading cause. Experimental data indicate that cytokines are involved in controlling CVB3 replication. Therefore, recombinant CVB3 (CVB3rec) varia
American Society for Microbiology.